As recently announced by the Association of American Cancer Institutes, an abstract created in a collaboration by the University of Cincinnati Cancer Institute and Complion has been awarded first place by the AACI CRI steering committee and selected to be presented in formal sessions at the 10th Annual AACI Clinical Research Initiative Meeting, July 11-12, in Chicago.
Selected from among a record 68 submissions, the winning entry, “Building a Strong Foundation: How Leveraging Cross Collaboration Can Improve Standardization and Adoption of an eRegulatory Solution,” was written by Trisha Wise-Draper, MD, PhD; Justin Osborne; Benjamin Quast, MBA, CCRP; Emily Werff, all from the University of Cincinnati Cancer Institute, and Michael Hurley, MBA, of Complion.
The abstract addresses lack of standardization in regulatory processes and technology adoption among clinical research institutions.The University of Cincinnati Cancer Institute (UCCI) collaborated with the UC Health Office of Clinical Research (OCR) to roll-out out an enterprise-wide eRegulatory system based on an NCI Standard developed by Complion by curating commonalities from 10 NCI designated Cancer Centers. The UCCI Cancer Standard was leveraged to create a Non-Cancer Standard that will be adopted across the institution.
The team from University of Cincinnati Cancer Institute will present the formal session at the Association of American Cancer Institutes event in Chicago.
Rick Arlow, Founder and CEO of Complion, will also be presenting "Automating Regulatory Processes to Ignite Quality & Efficiency" at the event. The session will explore how Complion's eRegulatory solution is automating regulatory processes to improve productivity and ensure adherence to SOPs.
Complion is very proud to have played a role in this effort, and wishes to extend congratulations to the University of Cincinnati Cancer Institute team for this remarkable achievement.